Companies

UroGen Pharma Ltd. (URGN) SEC filings

CIK 0001668243 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in L3 · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)109.8 M82.7 M64.4 M
Net income (USD)-109.8 M-110.8 M

Latest filings

FiledFormDescriptionPeriod
2026-10-094FORM 42026-10-08
2026-10-09144144
2026-09-094FORM 42026-09-07
2026-09-094FORM 42026-09-07
2026-09-09144144
2026-09-09144144
2026-08-284FORM 42026-08-26
2026-08-244FORM 42026-08-20
2026-08-20144144
2026-08-208-KFORM 8-K items 8.012026-08-18
2026-08-12SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-0510-QFORM 10-Q2026-06-30
2026-08-058-KFORM 8-K items 2.02,9.012026-08-05
2026-07-104FORM 42026-07-09
2026-07-09144144
2026-06-244FORM 42026-06-22
2026-06-244FORM 42026-06-22
2026-06-244FORM 42026-06-22
2026-06-244FORM 42026-06-22
2026-06-244FORM 42026-06-22
2026-06-244FORM 42026-06-22
2026-06-244FORM 42026-06-22
2026-06-238-KFORM 8-K items 3.03,5.02,5.07,9.012026-06-22
2026-06-22144144
2026-06-094FORM 42026-06-08

Forms on file (last 1,000): 4 196, 8-K 84, SC 13G/A 32, 6-K 27, 10-Q 23, 3 20, 144 20, SC 13G 20. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=URGN (0.002 USD), /gw/filings/filings?ticker=URGN&form=8-K, /gw/filings/facts?ticker=URGN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange